Apr 23, 2018 7:05am EDT Immunovaccine to Present at Bloom Burton & Co. Healthcare Investor Conference
Apr 17, 2018 7:05am EDT Immunovaccine Announces Leading Independent Proxy Advisory Firms Recommend Voting for Share Consolidation Related to Potential Nasdaq Listing
Apr 16, 2018 9:05am EDT New Preclinical Studies Reinforce the Potential for Heightened Anti-Cancer Activity of Combination Therapies Based on Immunovaccine’s Proprietary Delivery Platform
Mar 28, 2018 7:05am EDT Immunovaccine Announces Initiation of Patient Dosing in Investigator-Sponsored Phase 2 Clinical Trial of Its Lead Candidate DPX-Survivac Used in Combination with Pembrolizumab in Patients with DLBCL
Mar 19, 2018 5:05pm EDT Immunovaccine Researchers to Present New Preclinical Data at AACR Annual Meeting 2018
Mar 08, 2018 5:05pm EST Immunovaccine Chief Medical Officer Dr. Gabriela Rosu to Present at the Oncology Meeting Innovations (OMI) Annual Summit on Hematologic Malignancies